Urol. praxi, 2012; 13(3): 117-118
Use of botulinum toxin in urology
- Urologická klinika FN Hradec Králové
Botulinum toxin is a neurotoxin produced by anaerobic genus Clostridium. In the past it was one of the most feared poisons. Now is
widely studied in medicine and used in more than 250 indications. In addition to ophthalmology, aesthetic surgery, gastroenterology
and neurology with its positive effects are also used by urology. Most often it is the treatment of neurogenic and non-neurogenic detrusor
overactivity of the bladder. In smaller extent it is used also for other indications. In addition to its undeniably positive effects but it
is necessary to think of serious side effects.
Keywords: botulinum toxin, neurogenic detrusor overactivity, non-neurogenic overactive bladder, benign prostatic hyperplasia
Published: June 4, 2012 Show citation
References
- Šámal V. Botulinumtoxin a jeho aktuální možnosti použití v urologii. Ces Urol, 2009; 13(3): 199-206.
- Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiological Reviews, 1992; 56(1): 80-99.
Go to original source... 
Go to PubMed... - Krhut J. Botulotoxin - struktura, mechanizmus účinku a klinické použití. Urol. praxi, 2006; 5: 278-282.
- Krhut J. Neurourologie. Praha, Galen; 2005: 44-46.
- Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Uro, 2003; 44: 165-174. Go to original source... Go to PubMed...
- Schurch B, Stöhrer M, Kramer G, Schmid D, Gaul G, Hauri D. Botulinum - a-toxin for treating detrusor hyperreflexia in spinal cord injured patiens: a new alternative to a nticholinergic drugs? Preliminary results. J Urol, 2000; 164: 692-699. Go to original source... Go to PubMed...
- Mahfouz W, Corcos J. Role botulotoxinu při léčbě dysfunkce dolních cest močových u pacientů s roztroušenou sklerózou. Urol List, 2011; 9(3): 53-57.
- Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol, 1988; 139: 919-922. Go to original source... Go to PubMed...
- Jost WH. Treatment of detrusor-sphincter dyssynergia with botulinum toxin. J Neurol, 1999; 246: 89.
- Moore C, Rackley R, Goldman H. Urologic applications of botox. Current Bladder Dysfunction Reports, 2006; 1(2): 99-103. Go to original source...
- Tincello DG, Kenyon S, Abrams KR, Mayne C, Toozs-Hobson P, Taylor D, Slack M. Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study). Eur Urol. 2012: 5. Go to original source... Go to PubMed...
- Radziszewski P, Borkowski A. Botulinum toxin type A intravesical injections for instable bladder overactivity. Eur Urol Suppl, 2002; 1(1): 134. Go to original source...
- Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol, 2001; 165(4): 1107-1110. Go to original source... Go to PubMed...
- Kuo H. Effectiveness of periurethral botulinum toxin injection in the treatment of voiding dysfunction due to detrusor underactivity and non-relaxing urethra. Neurourol Urodyn, 2002; 21(4): 387-388.
- Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patiens with chronic prostatic pain? Eur Urol, 2000; 38(4): 393-399. Go to original source... Go to PubMed...